Works matching IS 09612033 AND DT 2016 AND VI 25 AND IP 4

Results: 19

Postural Orthostatic Tachycardia Syndrome (POTS) – A novel member of the autoimmune family.

Published in:

Lupus, 2016, v. 25, n. 4, p. 339, doi. 10.1177/0961203316629558

By:

Dahan, S.;
Tomljenovic, L.;
Shoenfeld, Y.

Publication type:

Article

Pregnancies in women with systemic lupus erythematosus and antiphospholipid antibodies.

Published in:

Lupus, 2016, v. 25, n. 4, p. 343, doi. 10.1177/0961203315627201

By:

Schreiber, K.

Publication type:

Article

Acute macular neuroretinopathy associated with systemic lupus erythematosus.

Published in:

2016

By:

Lee, D. H.;
Lee, S. C.;
Kim, M.

Publication type:

Case Study

Simple screening tool for assessing attention deficit in pediatric lupus.

Published in:

Lupus, 2016, v. 25, n. 4, p. 447, doi. 10.1177/0961203315619032

By:

Nuruzzaman, F.;
Sherman, Y.;
Ostfeld, B. M.;
Adams, A. B.;
Pan, N.;
Barinstein, L. V.;
Lehman, T. J. A.;
Moorthy, L. N.

Publication type:

Article

Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome.

Published in:

Lupus, 2016, v. 25, n. 4, p. 389, doi. 10.1177/0961203315618267

By:

Jakiela, B.;
Iwaniec, T.;
Plutecka, H.;
Celinska-Lowenhoff, M.;
Dziedzina, S.;
Musial, J.

Publication type:

Article

Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study.

Published in:

Lupus, 2016, v. 25, n. 4, p. 382, doi. 10.1177/0961203315617843

By:

Chung, W-S;
Lin, C-L;
Kao, C-H

Publication type:

Article

Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome.

Published in:

Lupus, 2016, v. 25, n. 4, p. 418, doi. 10.1177/0961203315617540

By:

Averina, M.;
Johannesen, S.;
Brox, J.

Publication type:

Article

Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.

Published in:

Lupus, 2016, v. 25, n. 4, p. 436, doi. 10.1177/0961203315617539

By:

Akawatcharangura, P.;
Taechakraichana, N.;
Osiri, M.

Publication type:

Article

BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.

Published in:

Lupus, 2016, v. 25, n. 4, p. 412, doi. 10.1177/0961203315615222

By:

Picceli, V. F.;
Skare, T. L.;
Nisihara, R. M.;
Nass, F. R.;
Messias-Reason, I. T.;
Utiyama, S. R. R.

Publication type:

Article

Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.

Published in:

2016

By:

Ungprasert, P.;
Chowdhary, V. R.;
Davis, M. D.;
Makol, A.

Publication type:

Case Study

Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.

Published in:

Lupus, 2016, v. 25, n. 4, p. 399, doi. 10.1177/0961203315615220

By:

Aragon, E.;
Resontoc, L. P.;
Chan, Y. H.;
Lau, Y. W.;
Tan, P. H.;
Loh, H. L.;
Ng, K. H.;
Yap, H. K.

Publication type:

Article

Streptococcus pneumoniae necrotizing fasciitis in systemic lupus erythematosus.

Published in:

Lupus, 2016, v. 25, n. 4, p. 423, doi. 10.1177/0961203315611498

By:

Sánchez, A.;
Robaina, R.;
Pérez, G.;
Cairoli, E.

Publication type:

Article

Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.

Published in:

Lupus, 2016, v. 25, n. 4, p. 376, doi. 10.1177/0961203315610645

By:

Drucker, A. M.;
Su, J.;
Mussani, F.;
Siddha, S. K.;
Gladman, D. D.;
Urowitz, M. B.

Publication type:

Article

Characteristics and information searched for by French patients with systemic lupus erythematosus: A web-community data-driven online survey.

Published in:

Lupus, 2016, v. 25, n. 4, p. 370, doi. 10.1177/0961203315610644

By:

Meunier, B.;
Jourde-Chiche, N.;
Mancini, J.;
Chekroun, M.;
Retornaz, F.;
Chiche, L.

Publication type:

Article

Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.

Published in:

Lupus, 2016, v. 25, n. 4, p. 364, doi. 10.1177/0961203315610206

By:

Fragoso-Loyo, H.;
Atisha-Fregoso, Y.;
Nuñez-Alvarez, C. A.;
Llorente, L.

Publication type:

Article

Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity.

Published in:

Lupus, 2016, v. 25, n. 4, p. 407, doi. 10.1177/0961203315608959

By:

Midgley, A.;
Beresford, M. W.

Publication type:

Article

Posterior reversible encephalopathy syndrome in a patient with lupus nephritis on rituximab therapy: a challenge to find the offender.

Published in:

2016

By:

Mondal, S.;
Goswami, R. Prosad;
Sinha, D.;
Basu, K.;
Das, S.;
Ghosh, P.;
Ghosh, A.

Publication type:

Case Study

Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.

Published in:

Lupus, 2016, v. 25, n. 4, p. 355, doi. 10.1177/0961203315606983

By:

das Chagas Medeiros, M. M.;
Bezerra, M. Campos;
Braga, F. N. Holanda Ferreira;
da Justa Feijão, M. R. Melo;
Gois, A. C. Rodrigues;
Rebouças, V. C. do Rosário;
de Carvalho, T. M. Amorim Zaranza;
Carvalho, L. N. Solon;
Ribeiro, ÁT Mendes

Publication type:

Article

Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.

Published in:

Lupus, 2016, v. 25, n. 4, p. 346, doi. 10.1177/0961203315604909

By:

Roth, D. A.;
Thompson, A.;
Tang, Y.;
Hammer, A. E.;
Molta, C. T.;
Gordon, D.

Publication type:

Article